Literature DB >> 30101015

Atypical presentation of a cushion sign-positive stomach gastrointestinal stromal tumor with cystic formation: A case report.

Yutaka Okagawa1, Tetsuya Sumiyoshi1, Hideyuki Ihara1, Shutaro Oiwa1, Kaho Tokuchi1, Masahiro Yoshida1, Ryoji Fujii1, Takeyoshi Minagawa1, Kohtaro Morita1, Michiaki Hirayama1, Hitoshi Kondo1, Yumiko Oyamada2, Yo Kawarada3, Shuji Kitashiro3, Shunichi Okushiba3.   

Abstract

Gastrointestinal stromal tumors (GIST) typically appear as solid masses, and cystic formation is uncommon. Most stomach GISTs with cystic formation progress outside the gastric wall and are frequently misdiagnosed as epigastric cystic tumors derived from pancreas or liver. An asymptomatic 72-year-old male underwent esophagogastroduodenoscopy, which revealed a submucosal tumor (SMT), approximately 50 mm in diameter, at the anterior wall of the gastric angle. The SMT was very soft with positive cushion sign. Endoscopic ultrasonography and contrast-enhanced computed tomography revealed that the SMT was a cystic tumor with solid component. Laparoscopic and endoscopic cooperative surgery were performed to remove the tumor. Histopathological analysis revealed that the tumor was a GIST with cystic formation. To the best of our knowledge, this the first documented case of a cushion sign-positive stomach GIST with cystic formation, which had mainly developed inside the stomach. This case suggests that we should keep in mind the possibility of cystic formation of GIST when the tumor has a solid component, even if it appears as a cushion sign-positive SMT.

Entities:  

Keywords:  cushion sign; cystic formation; gastrointestinal stromal tumor

Year:  2018        PMID: 30101015      PMCID: PMC6083422          DOI: 10.3892/mco.2018.1639

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


Introduction

Gastrointestinal stromal tumors (GISTs) are the most common type of mesenchymal neoplasms that originate from the interstitial cell of Cajal (1,2). Most of these tumors originate from the stomach (60%), followed by the small intestine (30%), and the colon (5%) (3). GISTs are classified as intramural, exoluminal, endoluminal, or mixed types, according to tumor location (4). GISTs are considered to have malignant potential, and several risk classifications have been proposed (5–7). Recently, Joensuu's classification system, which includes tumor size, mitotic figures, organ of origin, and presence of rupture, is often used (7). Typically, GISTs appear as solid masses and rarely present with cystic formations (8–16). The cystic formation is reportedly caused by hemorrhage or necrosis (17). Most stomach GISTs with cystic formations progress with an exoluminal or intramural pattern and are frequently misdiagnosed as epigastric cystic tumors derived from the pancreas or liver (13,15,16). Cushion sign refers to the morphometric fluctuation of the submucosal tumor by forceps compression (18), which is generally a characteristic of very soft or cystic tumors, such as lipomas or lymphangiomas. We report a rare case of a cushion sign-positive stomach GIST with cystic formation, which mainly developed inside the stomach.

Case report

A 72-year-old male, with a past medical history of gastric ulcer, was referred to our hospital for further examination of an abnormality in the stomach that was found by an esophagogastroduodenoscopy (EGD) performed for a health checkup. He had no abdominal symptoms, and his blood tests were normal, including levels of carcinoembryonic antigen and carbohydrate antigen 19-9 tumor markers. EGD revealed a mass covered by normal mucosa with a bridging fold, approximately 50 mm in diameter, at the anterior wall of the gastric angle (Fig. 1A). The submucosal tumor (SMT) was round and smooth, without erosions or ulcers. The SMT was very soft, with positive cushion sign when we used forceps to compress the tumor (Fig. 1B). The mass was thought to be a benign tumor, such as a lymphangioma, because the inside of the tumor was considered to contain liquid. However, contrast-enhanced abdominal computed tomography (CT) showed a mass containing both cystic and solid areas, mainly growing inside the stomach, and revealed enhancement of the solid portion and peripheral rim of the tumor (Fig. 2). Furthermore, endoscopic ultrasound (EUS) using a convex-type scope revealed a cystic tumor with solid component located in the third to fourth layer of the stomach and part of the solid component that had developed outside the stomach (Fig. 3). The cystic component appeared as low-level echoes. Subsequently, EUS-fine needle aspiration (EUS-FNA) of the solid component was performed for definitive diagnosis. Histologically, specimens obtained via EUS-FNA included spindle tumor cells. Immunohistochemical analysis of the specimens revealed that they were diffusely positive for c-kit and CD34; therefore, the tumor was diagnosed as GIST. However we considered laparoscopic partial gastrectomy or laparoscopic and endoscopic cooperative surgery (LECS) to treat the tumor, we employed LECS for more reliable resection. The patient underwent LECS to remove the GIST. Intraoperative laparoscopic findings showed soft tissue arising from the anterior wall of the stomach, freely mobile in the peritoneal cavity (Fig. 4). Although the lesion was located at the serosa side of the gastric SMT, there were no findings of peritoneal dissemination. The tumor was completely removed, and no intraoperative or postoperative complications were observed. The patient was discharged from our hospital within a week.
Figure 1.

A: EGD revealed an SMT, approximately 50 mm in diameter, at the anterior wall of the gastric angle. B: The SMT was very soft, and cushion sign was positive.

Figure 2.

Contrast-enhanced abdominal CT showed a mass containing both cystic and solid lesions, mainly growing inside the stomach.

Figure 3.

EUS revealed a cystic tumor with solid component located in the third to fourth layer of the stomach. Part of the solid component developed outside the gastric wall (arrow).

Figure 4.

Intraoperative laparoscopic findings revealed a soft tissue arising from the anterior wall of the stomach.

Macroscopically, the mass measured 57×51×13 mm, comprising both solid and cystic regions (Fig. 5A). Most of the tumor seen on endoscopy was the cystic component, which was filled with bloody serous fluid. Histopathological findings revealed that the tumor was located in the submucosal to muscularis layer of the stomach, and the cystic component was located in the submucosal layer. The cystic component showed hemorrhage, but no necrosis. Although part of the tumor projected toward the serosa, forming the lesion as seen on laparoscopy, there were no findings of serosal invasion. Histopathological analysis of the tumor revealed the spindle cells (Fig. 5B). The tumor cells were immunostained with anti-c-kit (CA4502, 1:200 dilution; Dako Japan, Tokyo, Japan), CD34 (NCL-L-END, 1:800 dilution), S-100 (NCL-L-S100p, 1:100 dilution), desmin (NCL-L-DES-DERII, 1:100 dilution), and smooth muscle actin (SMA) (NCL-L-SMA, 1:200 dilution) (all from Leica Biosystems, Newcastle, UK). These cells were positive for c-kit and CD34 (Fig. 5C and D), and negative for S-100, desmin (Fig. 5E and F) and SMA, and the mitotic count was 2/50 high-power fields. The tumor was diagnosed as a mixed-type GIST with cystic formation, belonging to the intermediate-risk group, based on Joensuu's classification system. The patient received no adjuvant therapy and continues to do well without recurrence for 40 months after LECS. Written informed consent for this case report was obtained from the patient.
Figure 5.

(A) Macroscopically, the mass consisted of both solid and cystic regions. (B) Histopathological analysis showed the spindle cells (magnification, ×200). The cells were positive for (C) c-kit and (D) CD34, and negative for (E) S-100 and (F) desmin (magnification, ×200).

Discussion

Cysts are macroscopically identified in ~50% of GISTs (19); however, stomach GISTs are usually solid tumors and seldom exhibit predominant cystic formations clinically. A few reported cases developed cystic changes, and the majority of these were cases of large GISTs, progressing as exoluminal or intramural patterns and misdiagnosed as epigastric cystic tumors derived from other organs (Table I). In the present case, most of the tumor developed inside the stomach, with positive cushion sign, and presented unique form. To our best knowledge, this is the first case to report a cushion sign-positive stomach GIST presented in an atypical form. The cystic space of GIST is reportedly formed by hemorrhage or necrosis (17). Hypervascular tumors may lead to internal bleeding, and necrosis can be caused by recurrent congestion, hemorrhage, or edema when the tumors grow faster than the capacity of blood supply or vein drainage (20). In the present case, the cystic component contained bloody serous fluid, without necrosis. This tumor might tend to have hemorrhage because of the presence of numerous blood vessels pathologically.
Table I.

Summary of cases of stomach GIST with cystic formation.

No.AuthorsAge (years)SexSize (cm)Growth patternMitotic index (HPFs)Treatment(Refs.)
1Park et al11F10ExoluminalNASurgical resection and chemotherapy(8)
2Osada et al74M12IntramuralNASurgical resection and chemotherapy(9)
3Cruz et al37M32Exoluminal10/50Surgical resection and chemotherapy(10)
4Yu et al81F6NA4/50Surgical resection(11)
5Notani et al85M22Exoluminal250-500/50Surgical resection and chemotherapy(12)
6Zuh et al78M17Exoluminal>10/50Surgical resection(13)
7Okano et al79M6Intramural<5/50Surgical resection(14)
8Hamza et al74F6.6Exoluminal1/50Surgical resection and chemotherapy(15)
9Sun et al75M13Exoluminal<5/50Surgical resection and chemotherapy(16)
10Present case72M5.7Mixed2/50LECS

GIST, gastrointestinal stromal tumors; HPF, high power fields; M, male; F, female; NA, not available.

The Japanese guidelines for gastric SMT recommend detailed examination with CT with contrast enhancement, EUS, and/or EUS-FNA when SMTs are 2–5 cm in diameter (21). In addition, EUS is reported to be useful modalities for diagnosing GISTs with cystic formation (14). In the present case, we initially thought the tumor was a lymphangioma, as the SMT was very soft and cushion sign was positive. However, it was highly important to conduct contrast-enhanced CT, EUS and EUS-FNA, according to the guidelines. Recently, LECS has developed as a safe and feasible procedure for the resection of gastric SMTs (22), and we selected tumor removal using LECS. The laparoscopic findings showed that part of GIST was arising from the gastric wall, which was the lesion outside the stomach as seen on EUS. EUS was also a useful modality for diagnosing the extension of GIST in this case. In the present case, GIST belonged to the intermediate-risk group due to the tumor size. However, some reports have suggested that the real tumor volume may be smaller than the imaging volume on cases of cystic GIST (13,23). It is controversial that a component of cystic lesion is included in the tumor size. Examination of additional cases is necessary for accurate risk classification of GIST with cystic formation. For high-risk group of GIST, administration of imatinib for 3 years is recommended as adjuvant chemotherapy (24), and the effect of imatinib has been identified to be related to c-kit and PDGFR mutations (25). Because this case belonged to the intermediate-risk group, we did not search those mutations. However, if this case recurs in the future, it is important to examine these mutations. In conclusion, we reported a rare case of a cushion sign-positive stomach GIST with cystic formation. This case suggests that the possibility of cystic formation of malignant tumor, such as GIST, should be kept in mind when the tumor is large and has a solid component, even if it appears as a cushion sign-positive SMT.
  24 in total

1.  Multifocal gastrointestinal stromal tumor (GIST) of the stomach in an 11-year-old girl.

Authors:  Jin Park; Tara C Rubinas; Lynn Ansley Fordham; J Duncan Phillips
Journal:  Pediatr Radiol       Date:  2006-09-13

2.  Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.

Authors:  M Miettinen; M Furlong; M Sarlomo-Rikala; A Burke; L H Sobin; J Lasota
Journal:  Am J Surg Pathol       Date:  2001-09       Impact factor: 6.394

Review 3.  Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

Authors:  Heikki Joensuu; Aki Vehtari; Jaakko Riihimäki; Toshirou Nishida; Sonja E Steigen; Peter Brabec; Lukas Plank; Bengt Nilsson; Claudia Cirilli; Chiara Braconi; Andrea Bordoni; Magnus K Magnusson; Zdenek Linke; Jozef Sufliarsky; Massimo Federico; Jon G Jonasson; Angelo Paolo Dei Tos; Piotr Rutkowski
Journal:  Lancet Oncol       Date:  2011-12-06       Impact factor: 41.316

4.  A case of a stomach gastrointestinal stromal tumor with extremely predominant cystic formation.

Authors:  Hiroshi Okano; Tomomasa Tochio; Daisuke Suga; Hiroaki Kumazawa; Yoshiaki Isono; Hiroki Tanaka; Shimpei Matsusaki; Tomohiro Sase; Tomonori Saito; Katsumi Mukai; Akira Nishimura; Youichirou Baba; Tetsuya Murata
Journal:  Clin J Gastroenterol       Date:  2015-06-26

Review 5.  Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis.

Authors:  Arash Nowain; Hetal Bhakta; Shireen Pais; Gary Kanel; Sumita Verma
Journal:  J Gastroenterol Hepatol       Date:  2005-06       Impact factor: 4.029

6.  Laparoscopic and luminal endoscopic cooperative surgery can be a standard treatment for submucosal tumors of the stomach: a retrospective multicenter study.

Authors:  Tatsuo Matsuda; Souya Nunobe; Toshiyuki Kosuga; Hiroshi Kawahira; Noriyuki Inaki; Shuji Kitashiro; Nobutsugu Abe; Isao Miyashiro; Sayaka Nagao; Masahiko Nishizaki; Naoki Hiki
Journal:  Endoscopy       Date:  2017-04-10       Impact factor: 10.093

7.  Atypical presentation of a gastric stromal tumor masquerading as a giant intraabdominal cyst: A case report.

Authors:  Ke-Kang Sun; Song Xu; Jinzhen Chen; Gang Liu; Xiaojun Shen; Xiaoyang Wu
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

8.  Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors.

Authors:  Andrey Frolov; Santiago Chahwan; Michael Ochs; Juan Pablo Arnoletti; Zhong-Zong Pan; Olga Favorova; Jonathan Fletcher; Margaret von Mehren; Burton Eisenberg; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2003-08       Impact factor: 6.261

Review 9.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

10.  Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

Authors:  Heikki Joensuu
Journal:  Hum Pathol       Date:  2008-10       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.